Showing results (1621-1630 of 1,832) with videos related to
Sort By:
Pageof 184
Acta Biomaterialia|August 2, 2015
Interlaboratory studies on in vitro test methods for estimating in vivo resorption of calcium phosphate ceramicsAtsuo Ito, Yu Sogo, Atsushi Yamazaki, et al.Human Cell|October 30, 2017
A common variant of MAF/c-MAF, transcriptional factor gene in the kidney, is associated with gout susceptibilityToshihide Higashino, Hirotaka Matsuo, Yukinori Okada, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 25, 2019
Female dominant association of sarcopenia and physical frailty in mild cognitive impairment and Alzheimer's diseaseYasuyuki Ohta, Emi Nomura, Noriko Hatanaka, et al.Journal of Cardiovascular Pharmacology|July 26, 2022
Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin CardiotoxicityTomonori Tadokoro, Masataka Ikeda, Ko Abe, et al.Case Reports in Oncology|August 11, 2022
Histopathology and Cytology of Pulmonary Myoepithelial Neoplasms: 2 CasesAkira Ishikawa, Hiroki Fujisawa, Naoko Yasumura, et al.Oncology Letters|July 11, 2019
Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinomaKyoko Oura, Koji Fujita, Asahiro Morishita, et al.Cell Stem Cell|June 3, 2018
A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord InjuryErik Curtis, Joel R Martin, Brandon Gabel, et al.Internal Medicine (Tokyo, Japan)|August 14, 2018
Neurolymphomatosis in the Cauda Equina Diagnosed by an Open BiopsyRyo Sasaki, Yasuyuki Ohta, Yuto Yamada, et al.Epilepsia Open|March 29, 2018
PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps-an ILAE PNES Task Force reportKousuke Kanemoto, W Curt LaFrance, Roderick Duncan, et al.International Journal of Oncology|February 13, 2009
Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II)Yasuhiro Ogawa, Kei Kubota, Hironobu Ue, et al.Pageof 184